CORE
COnnecting
REpositories
  • Services overviewExplore all CORE services
  • Access to raw data

    • API
    • Dataset
    • FastSync
  • Content discovery

    • Recommender
    • Discovery
  • OAI identifiers

    • OAI Resolver
  • Managing content

    • Dashboard
  • Bespoke contracts

    • Consultancy services
  • Support us

      MembershipSponsorshipResearch partnership
  • About

    • About us
    • Our mission
    • Team
    • Blog
    • FAQs
    • Contact us
  • Community governance

    • Governance
    • Advisory Board
    • Board of supporters
    • Research network
  • Innovations

    • Our research
    • Labs

    3 research outputs found

    Clozapine versus typical neuroleptic medication for schizophrenia

    Author
    1. Adib Essali
    2. Kristian Wahlbeck
    3. Maxim V Cheine
    Publication venue
    Wiley
    Publication date
    25/10/1999
    Field of study
    No full text
    Crossref

    Efficacy of β-blocker supplementation for schizophrenia: a systematic review of randomized trials

    Author
    1. Juha Ahonen
    2. Kristian Wahlbeck
    3. Maxim V. Cheine
    4. Simon Gilbody
    Publication venue
    Elsevier BV
    Publication date
    01/01/2000
    Field of study
    Full text link
    Crossref

    Beta-Blocker Supplementation of Standard Drug Treatment for Schizophrenia

    Author
    1. Ahonen Juha
    2. Bardhan Sabyasachi
    3. Cheine Maxim V
    4. Shek Elena
    5. Wahlbeck Kristian
    Publication venue
    Oxford University Press
    Publication date
    Field of study
    No full text
    Crossref
    Julkari
    PubMed Central
    corecore

    CORE (COnnecting REpositories) is a not-for-profit service hosted by The Open University supported by CORE Members.

    Product
    • Services
    • Membership
    • Sponsorship
    • Labs
    Organisation
    • About us
    • Governance
    • Team
    • Data providers
    Support
    • Terms
    • FAQs
    • Blog
    • Contact us
    Writing about CORE?

    Discover our research outputs and cite our work.

    Follow us:
    COREAccessibilityCookiesPrivacy